Peer Review reports
From: Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
Original Submission | ||
---|---|---|
20 Oct 2021 | Submitted | Original manuscript |
12 Nov 2021 | Reviewed | Reviewer Report |
17 Nov 2021 | Reviewed | Reviewer Report - Yun Hak Kim |
2 Dec 2021 | Reviewed | Reviewer Report |
22 Dec 2021 | Author responded | Author comments - Anna Fäldt Beding |
Resubmission - Version 2 | ||
22 Dec 2021 | Submitted | Manuscript version 2 |
10 Jan 2022 | Author responded | Author comments - Anna Fäldt Beding |
Resubmission - Version 3 | ||
10 Jan 2022 | Submitted | Manuscript version 3 |
19 Jan 2022 | Author responded | Author comments - Anna Fäldt Beding |
Resubmission - Version 4 | ||
19 Jan 2022 | Submitted | Manuscript version 4 |
23 Jan 2022 | Author responded | Author comments - Anna Fäldt Beding |
Resubmission - Version 5 | ||
23 Jan 2022 | Submitted | Manuscript version 5 |
30 Jan 2022 | Reviewed | Reviewer Report |
30 Jan 2022 | Reviewed | Reviewer Report |
7 Feb 2022 | Reviewed | Reviewer Report - Yun Hak Kim |
26 Feb 2022 | Author responded | Author comments - Anna Fäldt Beding |
Resubmission - Version 6 | ||
26 Feb 2022 | Submitted | Manuscript version 6 |
2 Mar 2022 | Author responded | Author comments - Anna Fäldt Beding |
Resubmission - Version 7 | ||
2 Mar 2022 | Submitted | Manuscript version 7 |
3 Mar 2022 | Reviewed | Reviewer Report - Yun Hak Kim |
Resubmission - Version 8 | ||
Submitted | Manuscript version 8 | |
Publishing | ||
4 Mar 2022 | Editorially accepted | |
25 Mar 2022 | Article published | 10.1186/s12885-022-09371-0 |
You can find further information about peer review here.